Heron Therapeutics Completes Capital Restructuring, Includes Hercules Capital Facility
Heron Therapeutics, a commercial-stage biotechnology company, completed a capital restructuring designed to enhance the company’s financial flexibility, reduce total debt and support long-term growth. The multi-faceted refinancing transaction consisted of the following key components: A new senior credit facility with...
Read moreDetails









